Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)
to demonstrate the efficacy of a 2-week treatment by the antihistamine V0114CP 2.5 mg versus placebo in reducing symptoms during seasonal allergic rhinitis.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Dermo-Cosmétique
Update Il y a 4 ans
Effect of an antioxidant cosmetic skin cream on healthy participants
Background and study aims As we age our skin ages, leading to noticeable changes such as wrinkles, dark spots and dryness. It is though that one of the major causes of skin ageing is sun exposure. Whe...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Research Institute (Institut de Recherche Pierre Fabre) (France)
Update Il y a 4 ans
Effect of Structum® (chondroitin sulfate) on cartilage volume in knee osteoarthritis
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)
to demonstrate the efficacy of a 2-week treatment by the antihistamine V0114CP 2,5 mgversus placebo in reducing symptoms during seasonall allergic rhinitis
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament - IRPF
Update Il y a 4 ans
EFFECT OF V0251 IN ACUTE VERTIGO. A RANDOMISED DOUBLE-BLIND PLACEBO CONTROLLED STUDY
The primary objective of the study is to determine the efficacy of one single intravenous injection of 4g of V0251 on vertigo symptoms relief in patient presenting with an attack of acute vertigo from...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Etude randomisée, en groupes parallèles, en double insu, de l’efficacité de la méquitazine sur la symptomatologie et l’obstruction nasale chez des patients présentant une rhinite allergique perannuelle
évaluer l’efficacité de la méquitazine sur la symptomatologie nasale (rhinorrhée, prurit nasal, obstruction nasale, éternuement).
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
A DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, PLACEBO-CONTROLLED 10-WEEK STUDY ASSESSING THE EFFICACY AND SAFETY OF F2695 SR FLEXIBLE DOSE (75,100 MG /DAY) IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER EFFICACY AND TOLERANCE OF F2695 SR IN MAJOR DEPRESSIVE DISORDER
To study the clinical efficacy of F2695 SR flexible dose (75, 100 mg /day) compared to placebo in patients with MDD through the assessment of MADRS after 10 weeks of treatment.
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6